Advanced development and manufacturing support to make your business projects efficient & profitable.

Our activities are carried out in one of the largest biotechnology facilities in Southern Europe by a greatly committed team and in compliance with high-quality standards. This makes ADL BioPharma the reference partner for our customers both for the scaling-up and industrial manufacturing of their projects, and for the active pharmaceutical ingredients manufacturing.

Unlike other CDMO companies, ADL Biopharma provides a thorough know-how from an expert team combined with one of the widest scaling range in terms of capacity (from 50 L to 225 m3), enabling us to offer a comprehensive support service for your biotech projects.
Our integral service involves:

●        Technology transfer.
●        Development and optimisation of production processes.
●        Design and commissioning of downstream processes.
●        Industrial manufacturing of customised manufacturing processes.

Fermentation plant (CMO Services): Continuous optimisation of production processes

We are a European strategic partner to run sustainable and profitable full projects involving both the upstream and downstream stages for high-potency products production. ADL provides the start-up of the projects with the most efficient use of time and resources, further ensuring a long-term ability to meet increased demands from our customers. With a capacity of over 1.800 m3 distributed in different fermentation plants, together with a complementary equipment of over 170m3 of vegetative fermentation chamber capacity, more than 250 m3 of auxiliary tanks and continuous sterilizers and more than 25 distillation columns, all of them destined to the biotechnological production of:

• Food ingredients
• Flavours & Fragrances
• Functional Molecules
• Personal care & Cosmetics Ingredients

Manufacturing of Active Pharmaceutical Ingredients [APIs]

ADL´s offer includes a wide range of beta-lactam APIs either as part of our portfolio or manufactured on contract. In all cases, the manufacturing ensures cost-effectively productions made under the highest quality standards, in strict compliance with FDA and GMP regulations.


Our current API manufacturing capacity:

Sterile Production Plant:
Up to 30 MT capacity for beta lactamics antibiotics

Semisynthetic Oral Plant:
1.000 MT capacity.

High Potency Plant:
50 m3 capacity for fermentation of high potency active substances.